Cargando…

Clearance of meropenem during continuous renal replacement therapy in critically ill patients

Detalles Bibliográficos
Autores principales:	Thalhammer, F, Schenk, P, Burgmann, H, Hollenstein, UM, Ratheiser, K, Breyer, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 1999
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301770/ http://dx.doi.org/10.1186/cc442

Ejemplares similares

Continuous infusion versus intermittent administration of meropenem in critically ill patients: a pilot study
por: Thalhammer, F, et al.
Publicado: (1999)

Continuous renal replacement therapy in critically ill neonates
por: Rödi, S, et al.
Publicado: (1998)

Pharmacokinetics of meropenem in intensive care patients receiving continuous renal replacement therapy
por: Giles, LJ, et al.
Publicado: (1998)

Meropenem clearance by continuous haemofiltration: a comparison of in vivo and in vitro data
por: Giles, LJ, et al.
Publicado: (1999)

Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
por: Solé Violan, J, et al.
Publicado: (2014)

Nutritional protocols improve energy supply and reduce nitrogen loss in critical illness
por: Birner, V, et al.
Publicado: (1998)

Sudden increase in ICU-mortality rate: a look behind the stage applying continuous quality improvement
por: Ratheiser, K, et al.
Publicado: (1997)

Dosing patterns for continuous renal replacement therapy in the United States
por: Venkataraman, R, et al.
Publicado: (2001)

Population pharmacokinetics of standard-dose meropenem in critically ill patients on continuous renal replacement therapy: a prospective observational trial
por: Onichimowski, Dariusz, et al.
Publicado: (2020)

Heparin vs recombinant hirudin for anticoagulation in continuous renal replacement therapy
por: Vargas Hein, O, et al.
Publicado: (2000)

Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
por: Schatz, Lea Marie, et al.
Publicado: (2023)

Continuous versus bolus furosemide therapy in critically ill patients with fluid overload
por: Ostermann, M, et al.
Publicado: (2002)

Is there a role for continuous esophageal Doppler in critically ill patients?
por: Coelho, JMC, et al.
Publicado: (2003)

Continuous infusion of meropenem in critically ill patients: practical considerations
por: Taccone, Fabio Silvio
Publicado: (2012)

Continuous infusion of meropenem–vaborbactam for a KPC-3-producing Klebsiella pneumoniae bloodstream infection in a critically ill patient with augmented renal clearance
por: Larcher, Romaric, et al.
Publicado: (2023)

Continuous Renal Replacement Therapy in Critically Ill Children
por: Demirkol, Demet
Publicado: (2022)

Effects of customized bicarbonate buffered solutions for continuous renal replacement therapies on polymorphonuclear function and viability
por: Maccariello, E, et al.
Publicado: (2003)

Cefepime in critically ill patients: continuous infusion versus intermittent regimen
por: Georges, B, et al.
Publicado: (2001)

Correlation of the monitorization with continuous esophageal echo-Doppler in critically ill patients
por: Natera-Ramírez, L, et al.
Publicado: (2001)

Renal effects of low-dose dopamine in the critically ill
por: Juste, RN, et al.
Publicado: (1997)

1282. Ceftolozane/Tazobactam Use in Critically Ill Patients Receiving Intermittent or Continuous Renal Replacement Therapy
por: Henry, Molly, et al.
Publicado: (2021)

Neutrophil gelatinase-associated lipocalin clearance during veno-venous continuous renal replacement therapy in critically ill patients
por: de Geus, Hilde R. H., et al.
Publicado: (2010)

Bone resorption and acute renal failure in the hypercalcaemic critically ill
por: Ledson, JF, et al.
Publicado: (2001)

Outcome of patients with acute renal failure treated with intermittent or continuous renal replacement therapy depending on the initial diagnosis: a retrospective analysis
por: Schroeder, TH, et al.
Publicado: (2002)

Measuring dobutamine (Db) clearance during continuous hemofiltration (CHF)
por: Van der Linden, T, et al.
Publicado: (1998)

Renal replacement therapy for critically ill patients: an intermittent continuity
por: Ricci, Zaccaria, et al.
Publicado: (2014)

Clearance of micronutrients during continuous renal replacement therapy
por: Lumlertgul, Nuttha, et al.
Publicado: (2020)

2551. Assessing Meropenem Concentrations in Children with Septic Shock: Population-Based Pharmacokinetic (PK) Modeling of Meropenem Demonstrates Variability from Acute Kidney (AKI) to Augmented Renal Clearance (ARC)
por: Le, Jennifer, et al.
Publicado: (2023)

2526. Ex Vivo Assessment of Sulbactam-Durlobactam (SUL-DUR) Clearance during Continuous Renal Replacement Therapy (CRRT)
por: Abouelhassan, Yasmeen, et al.
Publicado: (2023)

Is the ecarin clotting time (ECT) a valid monitoring parameter for r-hirudin-based anticoagulation in continuous renal replacement therapy?
por: v Heymann, C, et al.
Publicado: (2000)

Outcome from acute renal failure complicating critical illness is influenced by age
por: Garfield, MJ, et al.
Publicado: (2003)

611. Meropenem Dosage Optimization in Critically Ill Patients Based on a Population Pharmacokinetic Approach.
por: Romano-Aguilar, Melissa, et al.
Publicado: (2022)

1298. Population Pharmacokinetics of Ceftazidime-avibactam among Critically-ill Patients with and without Receipt of Continuous Renal Replacement Therapy
por: Kline, Ellen G, et al.
Publicado: (2020)

A comparison between oesophageal Doppler and continuous thermodilution for the measurement of cardiac output in critically ill patients
por: Wilkinson, JR, et al.
Publicado: (2000)

Tedizolid clearance by in vitro continuous renal replacement therapy model
por: Lewis, SJ, et al.
Publicado: (2015)

Probiotics in critical illness
por: Klarin, B, et al.
Publicado: (1999)

402 Pharmacokinetics of Extended vs Intermittent Intravenous Infusion of Meropenem in Critically Ill Patients Receiving Continuous Veno-Venous Haemofiltration
por: Frippiat, Frédéric, et al.
Publicado: (2014)

Need for renal replacement therapy in ICU is a marker of morbidity
por: Ostermann, ME, et al.
Publicado: (2002)

PW01-036 – Renal replacement therapy in patients with FMF
por: Papazyan, M, et al.
Publicado: (2013)

Hemodynamic impact of the connection to continuous renal replacement therapy in critically ill children
por: Fernández, Sarah, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_260e0h9lgt959m1jr7t9fi1h00